Kelly M. Brady
Chief Tech/Sci/R&D Officer bei SERES THERAPEUTICS, INC.
Profil
Kelly M.
Brady is currently the Vice President-Clinical Operations at Seres Therapeutics, Inc. She previously worked as a Senior Director at Akebia Therapeutics, Inc. and as a Member-Operations Team at Osiris Therapeutics, Inc. Ms. Brady holds a graduate degree from The Johns Hopkins University and an undergraduate degree from Lafayette College.
Aktive Positionen von Kelly M. Brady
| Unternehmen | Position | Beginn |
|---|---|---|
| SERES THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01.06.2018 |
Ehemalige bekannte Positionen von Kelly M. Brady
| Unternehmen | Position | Ende |
|---|---|---|
| AKEBIA THERAPEUTICS, INC. | Corporate Officer/Principal | - |
| OSIRIS THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Ausbildung von Kelly M. Brady
| The Johns Hopkins University | Graduate Degree |
| Lafayette College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| AKEBIA THERAPEUTICS, INC. | Health Technology |
| SERES THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Osiris Therapeutics, Inc.
 Osiris Therapeutics, Inc. BiotechnologyHealth Technology Osiris Therapeutics, Inc. engages in the research, development, manufacture, and commercialization of regenerative medicine products. Its biosurgery business focuses on using unique tissue preservation technologies to develop viable human tissue products designed to improve wound closure and surgical outcomes for patients and physicians over standard of care alone. The company was founded by Peter A. Friedli and James S. Burns on December 23, 1992 and is headquartered in Columbia, MD. | Health Technology |
